|
Evaluation of the Interest of a Postural and Functional Analysis for the Follow-up of the Adapted Motor Activity of Patients Treated for Breast Cancer
RECRUITINGN/ASponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche
Actively Recruiting
PhaseN/A
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
Started2023-02-01
Est. completion2025-02-01
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05677022
Summary
The goal of this clinical trial is to evaluate the acceptability by patients treated for breast cancer of an adapted motor activity program over a period of 15 months controlled by a postural and functional analysis.. Participant population/health conditions: patients with newly operated breast cancer who are candidates for an adapted physical activity program
Eligibility
Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * Adult woman, having given her consent to participate in the study, * Patient with non-metastatic breast cancer, * Cancer to be treated by surgery with or without adjuvant treatment (radiotherapy and/or chemotherapy). Exclusion Criteria: * Contraindication to the practice of a physical activity, * Mental deficiency or any other reason that could hinder the understanding or the strict application of the protocol, * Patient not affiliated to the French social security system, * Patient under legal protection, guardianship or curatorship, * Patient already included in another therapeutic study protocol aimed at evaluating the benefits of adapted physical activity.
Conditions2
Breast CancerCancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
Started2023-02-01
Est. completion2025-02-01
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05677022